Other Stories

Moderna enters mid-stage of COVID-19 vaccine development Updated: 2020-05-31 09:14:51 KST

Moderna has announced Friday that it has entered phase two of vaccine clinical trials for COVID-19.
The mid-stage of the vaccine intends to enroll 6-hundred patients, and the first group of participants have already been dosed with the vaccine candidate.
Earlier this month, Moderna released positive results for the phase one study, showing that participants have developed antibodies against the virus.
There are currently around 10 vaccines for COVID-19 that are under clinical tests on humans.
Experts predict that it could take from 12 to 18 months for a safe and effective vaccine to be developed.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.